Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled multicenter trial of Yupingfeng granules in children with recurrent respiratory tract infections
CTR20252571Phase 2Active
- Sponsor
- Sinopharm
- Start
- Jul 2025
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of yupingfeng in Airways Infection, sponsored by Sinopharm. Started Jul 2025; status: active.
02
Drugs
yupingfeng
03
Conditions
Airways Infection
Beyond the preview
Go deeper on CTR20252571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252571.